TikoMed seeks partners for regenerative meds pipeline

Adam Bruce, CEO and founder of TikoMed AB, speaks to Informa Pharma Insights' global director of content Mike Ward about the Swedish firm's pipeline of regenerative medicine programs. TikoMed is currently seeking partners for two of its clinical stage programs that are targeting neurological indications like stroke and traumatic brain injury. The small company, which has just four employees and a board of directors, is seeking strategic advisors to help it secure successful deals with larger pharma companies.